Experts will guide participants through the product launch timeline from Phase 3 to commercial launch
Almac Pharma Services, part of the global CDMO Almac Group, is inviting members of the pharmaceutical and biotechnology industry to join its upcoming complimentary workshop series this September. Details of the programme are available online.
During these specifically designed knowledge sharing sessions, Almac’s subject matter experts will guide participants through the product launch timeline from Phase 3 to commercial launch and share valuable insights into the key requirements and considerations to ensure commercial launch in Europe is successful.
The three individual sessions will be hosted on the following dates:
Almac understands that launching a drug product can be challenging, especially if sponsors are not familiar with the key milestone requirements that should be met at various time points in the MA submission process.
Using real-life scenarios and interactive group discussions, participants will learn about the European regulatory framework and how this determines all launch milestones, understand the importance of the Qualified Person (QP) and QP declarations and identify top operational considerations as you progress to commercialisation and much more.
The combination of interactive presentations, round table discussions and networking at these events will prove invaluable for participants
Workshop host, Adam Schroeder, Director of Business Development at Almac Pharma Services, commented on the upcoming workshop: "We are excited to offer this series of workshops in three significant locations across the west coast.
"The combination of interactive presentations, round table discussions and networking at these events will prove invaluable for participants wishing to find out more about launching their product into Europe. We look forward to sharing our industry insights and expertise with those attending in September.”
